signatera for immunotherapy response monitoring
Published 3 years ago • 1.1K plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
0:40
how does signatera for immunotherapy response monitoring work?
-
3:26
steven's story: long-term stable disease on immunotherapy
-
2:54
signatera para el control de la respuesta a la inmunoterapia
-
2:27
the signatera approach
-
18:43
advances in testing: a personalized, ctdna assay for mrd detection and surveillance
-
0:38
introducing signatera, a personalized, tumor-informed test
-
49:45
a ctdna assay for remote monitoring and risk stratification
-
35:05
a ctdna assay for remote monitoring and risk stratification of crc patients
-
1:00:31
breast cancer signatera webinar
-
3:00
signacase: a case review: how being informed using signatera helped dan through his cancer journey
-
1:46
natera signatera product theater at sabcs 2022: the cycle of ctdna
-
2:33
arturo loaiza-bonilla, md | what is signatera?
-
1:39
about signatera and ctdna
-
2:19
introducing signatera, a personalized, tumor-informed test
-
0:41
natera signatera product theater sabcs 2022: ctdna utility
-
2:01
farshid dayyani, md | what is signatera?
-
1:00:12
signatera - asco highlights
-
1:00
7 things to know about immunotherapy
-
2:48
is the cancer coming back? using signatera to detect molecular residual disease (mrd)